Mechanistic target of rapamycin complex-2 (mTORc2) mediates the effect of over-night high K+ on Kir4.1/Kir4.1 in the DCT and ENaC/ROMK in ASDN. | American Journal of Physiology-Renal Physiology | Amer...

Power relations and role boundaries between community first responders and ambulance clinicians in England: a qualitative study

164414 Tenure Track Assistant Professor or Associate Professor of Biomedical Sciences

Accelerating Medicines Partnership in Type 2 Diabetes and Common Metabolic Diseases: Collaborating to Maximize the Value of Genetic and Genomic Data

Lincoln Professor Helping Shape the Future of Diabetic Kidney Disease Research | News and PressPrevious posts arrow navigation.Next posts arrow navigation.

Effect of sotagliflozin on major adverse cardiovascular events: a prespecified secondary analysis of the SCORED randomised trial

FDA Approves Ozempic for Kidney Disease | Docwire News

Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial - PubMed

Meon Vale mother of three who needs kidney makes donor appeal

FDA approves Novo Nordisk's Ozempic to treat chronic kidney disease in those with diabetes, expanding its use

Frontiers | Diagnosis and management of type 2 diabetes mellitus in patients with ischaemic heart disease and acute coronary syndromes - a review of evidence and recommendations

<em>Diabetic Medicine</em> | Diabetes UK Journal | Wiley Online Library

Paracrine role of endothelial IGF-1 receptor in depot-specific adipose tissue adaptation in male mice - Nature Communications

Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials

Hospitals trial AI to spot type 2 diabetes risk

Manchester: 'My former work colleague gave me her kidney'

Breakthrough T1D UK Small Grant Awards | Breakthrough T1D UK

A life-changing device for diabetics

Associate Professor / Professor of Evolutionary Genomics - Job Opportunities - University of Cambridge

Crosstalk of Hyperglycaemia and Cellular Mechanisms in the Pathogenesis of Diabetic Kidney Disease

Young adult-onset type 2 diabetes heralds a poor prognosis

Efficacy and Safety of Sotagliflozin in Patients with Type... : Journal of the American Society of Nephrology

Weight-loss drugs can improve kidney health, study finds

Cellular atlases are unlocking the mysteries of the human body

FLOW Trial Results Categorized by CKD Severity | Docwire News

Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants

ISN Webinar: How GLP1 receptor agonist evolved from weight management drugs to kidney protective therapy? - International Society of Nephrology

New approaches to acute kidney injury